We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont, Arcadia Jointly Develop ARA Oil from Safflower Plants
Read MoreHide Full Article
DuPont’s (DD - Free Report) unit DuPont Pioneer and Arcadia Biosciences, Inc. announced that they have successfully completed a field-trial validation of safflower plants that produce high levels of arachidonic acid (ARA) oil, which is a high-value, specialty nutritional oil, for global consumer markets. Achievement of this major milestone reflects a significant step taken jointly by the companies to develop a new plant-based and cost-effective source of oil with high levels of ARA.
ARA is an omega-6 fatty acid that plays a crucial role in the neural and visual development of infants, along with some omega-3 fatty acids. It is highly beneficial for infants. The U.S. Food and Drug Administration, the Food and Agriculture Organization of the United Nations and the World Health Organization have reviewed and supported its usage in nutritional products.
Safflower plants with high ARA will be instrumental in improving manufacturing economics and encouraging wider use of ARA by providing a better alternative and a more efficient source for the ingredient. Since only sunlight is required for the production of ARA in safflower seed oil, it will be a very cost-effective method of production unlike current commercial methods.
The development of ARA in safflower oil will enable Arcadia to expand its nutritional oil offerings and help DuPont to build its experience in the development, regulatory management, production and marketing of these high-value products.
Arcadia’s ARA safflower oil is in the late stages of product development. Regulatory approval will be required before commercialization of the oil. DuPont recorded higher profits in first-quarter 2016, supported by cost-management actions. Adjusted earnings for the quarter topped the Zacks Consensus Estimate. Revenues declined year over year due to unfavorable currency impact, but beat expectations. The company raised its earnings guidance for 2016.
While DuPont still faces a number of challenges, it is poised to gain from new product launches and productivity actions. Moreover, it remains committed to maximize shareholder value.
DuPont currently holds a Zacks Rank #2 (Buy).
Other well-ranked companies in the chemicals industry include Innophos Holdings Inc , Innospec Inc. (IOSP - Free Report) and Asahi Kasei Corp. (AHKSY - Free Report) , all sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
DuPont, Arcadia Jointly Develop ARA Oil from Safflower Plants
DuPont’s (DD - Free Report) unit DuPont Pioneer and Arcadia Biosciences, Inc. announced that they have successfully completed a field-trial validation of safflower plants that produce high levels of arachidonic acid (ARA) oil, which is a high-value, specialty nutritional oil, for global consumer markets. Achievement of this major milestone reflects a significant step taken jointly by the companies to develop a new plant-based and cost-effective source of oil with high levels of ARA.
ARA is an omega-6 fatty acid that plays a crucial role in the neural and visual development of infants, along with some omega-3 fatty acids. It is highly beneficial for infants. The U.S. Food and Drug Administration, the Food and Agriculture Organization of the United Nations and the World Health Organization have reviewed and supported its usage in nutritional products.
Safflower plants with high ARA will be instrumental in improving manufacturing economics and encouraging wider use of ARA by providing a better alternative and a more efficient source for the ingredient. Since only sunlight is required for the production of ARA in safflower seed oil, it will be a very cost-effective method of production unlike current commercial methods.
The development of ARA in safflower oil will enable Arcadia to expand its nutritional oil offerings and help DuPont to build its experience in the development, regulatory management, production and marketing of these high-value products.
Arcadia’s ARA safflower oil is in the late stages of product development. Regulatory approval will be required before commercialization of the oil.
DuPont recorded higher profits in first-quarter 2016, supported by cost-management actions. Adjusted earnings for the quarter topped the Zacks Consensus Estimate. Revenues declined year over year due to unfavorable currency impact, but beat expectations. The company raised its earnings guidance for 2016.
While DuPont still faces a number of challenges, it is poised to gain from new product launches and productivity actions. Moreover, it remains committed to maximize shareholder value.
DuPont currently holds a Zacks Rank #2 (Buy).
Other well-ranked companies in the chemicals industry include Innophos Holdings Inc , Innospec Inc. (IOSP - Free Report) and Asahi Kasei Corp. (AHKSY - Free Report) , all sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>